logo-loader
viewEXMceuticals

EXMceuticals adds leading UK cannabis lawyer Nick Davis to advisory team

Davis is the CEO and senior corporate partner at Memery Crystal, a London-based law firm

handshake
Davis is the CEO and senior corporate partner at Memery Crystal, a London-based law firm

EXMceuticals Inc (CSE:EXM) is tapping the expertise of a senior London lawyer with expertise in the cannabis sector as it continues to build up its European focus. 

Memery Crystal partner Nick Davis is joining EXMceuticals as a new board advisor to the management team, the Vancouver-based cannabis firm said Monday. 

Davis is the CEO and senior corporate partner at Memery Crystal, a London-based law firm with the leading cannabis practice in the UK.

READ: EXMceuticals taps Paulo Martins to lead Portugal operations

A highly-in-demand speaker and expert in medicinal cannabis, Davis led the listing of medicinal cannabis investment firm Ananda Developments on the NEX Exchange Growth Market. Ananda was the second public listing of a cannabis vehicle in the UK.

Davis also acts as a trustee on a uveitis charity that aims to raise awareness on the debilitating eye condition. The charity, Olivia’s Vision, is aptly named after Davis’s daughter, who lives with uveitis. The condition is one of the many autoimmune diseases being targeted for medical cannabis research.

EXMceuticals CEO Jonathan Summers said the appointment would strengthen the firm’s expertise and credibility, calling it “clearly positive” news.

“With his impressive background in corporate finance, and cannabis speciality, Mr. Davis will work closely with the board to maximise the value of the company’s assets,” Summers said in a statement.

“His market leading knowledge of the European cannabis markets will be a considerable addition for EXM as we progress with Portugal, and we are naturally proud to have him on the team.”

EXMceuticals is focused on the sustainable cultivation of cannabis and hemp, and the production of high-grade cannabis and hemp ingredients for the pharmaceutical, therapeutic. nutraceutical and cosmetic industries. 

Contact Angela at [email protected]

Follow her on Twitter @AHarmantas

Quick facts: EXMceuticals

Price: 0.22 CAD

CSE:EXM
Market: CSE
Market Cap: $8.73 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of EXMceuticals named herein, including the promotion by the Company of EXMceuticals in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

EXMceuticals secures critical R&D license for its Portugal cannabis facilities

EXMceuticals Inc's (CSE:EXM) Jonathan Summers speaks to Proactive London's Andrew Scott following the news they've obtained a licence for cannabis research and development from the Portuguese government. The license was granted by INFARMED - the Portuguese National Authority of Medicines and...

on 30/10/19

2 min read